FDA Launches Major Review of CGMPs

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

External Link - article-36195.pdf

Articles in this issue

almost 24 years ago

Article

Understanding Pharmaceutical Flows

almost 24 years ago

Article

Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

almost 24 years ago

Article

An Overview of the Validation Approach for Moist Heat Sterilization, Part II

almost 24 years ago

Article

Cyclodextrins as Sustained-Release Carriers

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

FDA Launches Major Review of CGMPs

Articles in this issue

Related Content

Pharma's Next AI Problem Is Authority

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

Trending on Pharmaceutical Technology

European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized

Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing

Technology Transfer: Success Drivers and Obstacles Explained

Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement

Data Aggregation Drives AI's Impact on Clinical Supply Chains